Bone necrosis around dental implants: a patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX
NAGIOS: RODERIC FUNCIONANDO

Bone necrosis around dental implants: a patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX

DSpace Repository

Bone necrosis around dental implants: a patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX

Show simple item record

dc.contributor.author Flichy, Patrice es
dc.contributor.author González Lemonnier, Sandra es
dc.contributor.author Balaguer Martínez, José es
dc.contributor.author Peñarrocha Oltra, David es
dc.contributor.author Peñarrocha Diago, Miguel es
dc.contributor.author Bagán Sebastián, José Vicente es
dc.date.accessioned 2014-05-21T12:15:10Z
dc.date.available 2014-05-21T12:15:10Z
dc.date.issued 2012 es
dc.identifier.uri http://hdl.handle.net/10550/35229
dc.source Flichy, Patrice ; González Lemonnier, Sandra ; Balaguer Martínez, José ; Peñarrocha Oltra, David ; Peñarrocha Diago, Miguel ; Bagán Sebastián, José Vicente. Bone necrosis around dental implants: a patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX. En: Journal of Clinical and Experimental Dentistry, 2012, Vol. 4, No. 1: 82-85 es
dc.subject Odontología es
dc.subject Ciencias de la salud es
dc.title Bone necrosis around dental implants: a patient treated with oral bisphosphonates, drug holiday and no risk according to serum CTX es
dc.type info:eu-repo/semantics/article en
dc.type info:eu-repo/semantics/publishedVersion en
dc.subject.unesco UNESCO::CIENCIAS MÉDICAS es
dc.description.abstractenglish Osteonecrosis of the jaw (ONJ) may appear following certain oral surgery procedures in patients treated with oral bisphosphonates (OB). Guidelines for the treatment of these patients were set out in the American Association of Oral and Maxillofacial Surgeons (AAOMS) Position Paper on Bisphosphonate-Related Osteonecrosis of The Jaws (Position Paper) and Approved by the Board of Trustees in September 2006. For the AAOMS the placement of implants in these patients is not contraindicated. In addition, the serum C-terminal telopeptide bone suppressor marker (CTX) test is available to determine the risk of ONJ. A case is presented of ONJ in a patient with 6 months of OB discontinuation ('drug holiday') before dental implant placement (following the guidelines of the AAOMS) and with no risk of osteonecrosis according to the serum CTX value (340 pg/ml). The wound healed favorably with complete healing at 7 months. In this case, the serum CTX test must be questioned as to its predictive value of ONJ, and more reliable markers of this risk are needed. es

View       (412.6Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics